Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced it has achieved certification for ISO 27001, the world’s leading standard for information security management systems, published by the International Organization for Standardization (ISO) in partnership with the International Electrotechnical Commission (IEC). This globally recognized accreditation reinforces Butterfly’s commitment to maintaining the highest standards of cybersecurity and data protection requirements.
“Achieving ISO 27001 and additional international certifications reflects our uncompromising commitment to protecting data and earning the trust of hospitals, health systems, and customers around the world,” said Mike Tiemeyer, Chief Information Security Officer of Butterfly Network. “These certifications demonstrate that Butterfly meets rigorous, globally recognized standards and is a reliable partner for secure, enterprise-grade medical imaging. We have the added assurance of being assessed by A-LIGN, a leader in global security audit services, as our third-party assessment organization (3PAO).”
Butterfly has also successfully completed certification for SOC-2 Type 2, C5 Germany (Cloud Computing Compliance Criteria Catalogue), and The National Health Service (NHS) Data Security and Protection Toolkit (DSPT), further strengthening its global security posture across the US, UK, EU, and international markets.
Butterfly’s President, Chief Executive Officer and Chairman, Joseph DeVivo added, “Security is foundational to scaling Butterfly globally. With these internationally recognized certifications, we’re affirming not only our technological leadership in point-of-care imaging, but also our dedication to meeting the highest standards of trust, compliance, and protection.”
The latest certification strengthens Butterfly’s growing security foundation. In late 2024, the Company became one of the first (and the first in medical imaging) to earn GovRAMP SnapShot and expects full GovRAMP authorization later this year (along with the similar TX-RAMP certification). It also anticipates securing FedRAMP certification and is pursuing HITRUST CSF r2, a NIST 800-53 (Rev-5) framework that unifies standards like HIPAA and GDPR.
About Butterfly Network
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.
Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251027179446/en/
